233 related articles for article (PubMed ID: 30663903)
1. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
[TBL] [Abstract][Full Text] [Related]
2. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
3. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
[TBL] [Abstract][Full Text] [Related]
4. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
Shady W; Petre EN; Vakiani E; Ziv E; Gonen M; Brown KT; Kemeny NE; Solomon SB; Solit DB; Sofocleous CT
Oncotarget; 2017 Sep; 8(39):66117-66127. PubMed ID: 29029497
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
[TBL] [Abstract][Full Text] [Related]
9. Single-centre retrospective review of risk factors for local tumour progression and complications in radiofrequency ablation of 555 hepatic lesions.
Chua JME; Lam YMP; Tan BS; Tay KH; Gogna A; Irani FG; Lo HGR; Too CW
Singapore Med J; 2019 Apr; 60(4):188-192. PubMed ID: 31069400
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and prognostic factors of cone-beam CT-guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients.
Hong HP; Kim HO; Koo DH; Lee YG; Kim MS; Ham SY; Kang DY; Oh TY; Lee H; Jung KU; Kim H
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e215-e222. PubMed ID: 35822242
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.
Vietti Violi N; Duran R; Demartines N; Sempoux C; Guiu B; Bize PE; Sala N; Halkic N; Knebel JF; Denys A
Int J Hyperthermia; 2018 Nov; 34(7):1020-1028. PubMed ID: 29506424
[TBL] [Abstract][Full Text] [Related]
12. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.
Wang X; Sofocleous CT; Erinjeri JP; Petre EN; Gonen M; Do KG; Brown KT; Covey AM; Brody LA; Alago W; Thornton RH; Kemeny NE; Solomon SB
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):166-75. PubMed ID: 22535243
[TBL] [Abstract][Full Text] [Related]
13. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.
Sofocleous CT; Petre EN; Gonen M; Brown KT; Solomon SB; Covey AM; Alago W; Brody LA; Thornton RH; D'Angelica M; Fong Y; Kemeny NE
J Vasc Interv Radiol; 2011 Jun; 22(6):755-61. PubMed ID: 21514841
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M
Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
[TBL] [Abstract][Full Text] [Related]
16. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression.
Benhaim L; El Hajjam M; Malafosse R; Sellier J; Julie C; Beauchet A; Nordlinger B; Peschaud F
HPB (Oxford); 2018 Jan; 20(1):76-82. PubMed ID: 29029986
[TBL] [Abstract][Full Text] [Related]
19. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided percutaneous radiofrequency ablation in treatment of neuroendocrine tumor liver metastases：a single-center experience.
Huang J; Liu B; Lin M; Zhang X; Zheng Y; Xie X; Xu M; Xie X
Int J Hyperthermia; 2022; 39(1):497-503. PubMed ID: 35285400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
